Ubs Oconnor LLC Annexon, Inc. Transaction History

Ubs Oconnor LLC

$1.72 Billion
Q2 2024

A detailed history of Ubs Oconnor LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Ubs Oconnor LLC holds 228,277 shares of ANNX stock, worth $1.59 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

228,277

Holding current value

$1.59 Million

% of portfolio

0.06%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.33 - $6.79 $86,600 - $135,800	-20,000 Reduced 8.06%	228,277 $1.12 Million
Q1 2024 May 15, 2024	SELL	$4.03 - $7.81 $1.79 Million - $3.47 Million	-444,651 Reduced 64.17%	248,277 $1.78 Million
Q4 2023 Feb 14, 2024	BUY	$1.63 - $4.63 $234,201 - $665,247	143,682 Added 26.16%	692,928 $3.15 Million
Q3 2023 Nov 14, 2023	BUY	$2.13 - $3.84 $263,459 - $474,969	123,690 Added 29.07%	549,246 $1.3 Million
Q2 2023 Aug 14, 2023	BUY	$2.1 - $6.37 $893,667 - $2.71 Million	425,556 New	425,556 $1.5 Billion
Q1 2023 May 15, 2023	BUY	$3.74 - $7.46 $29,725 - $59,292	7,948 Added 5.0%	166,907 $642,000
Q4 2022 Feb 14, 2023	BUY	$4.56 - $6.61 $169,641 - $245,905	37,202 Added 30.55%	158,959 $0
Q3 2022 Nov 14, 2022	SELL	$3.75 - $6.63 $37,848 - $66,916	-10,093 Reduced 7.65%	121,757 $752 Million
Q2 2022 Aug 12, 2022	SELL	$2.11 - $4.06 $264,066 - $508,108	-125,150 Reduced 48.7%	131,850 $497,000
Q1 2022 May 16, 2022	BUY	$2.73 - $11.94 $701,610 - $3.07 Million	257,000 New	257,000 $701,000

Others Institutions Holding ANNX

# of Institutions

158

Shares Held

101M

Call Options Held

3.61M

Put Options Held

1.08M

Bain Capital Life Sciences Investors, LLC Boston, MA

8.45M
Shares

$58.9 Million
8.47% of portfolio
Satter Management Co., L.P.

7.41M
Shares

$51.6 Million
71.21% of portfolio
Bvf Inc San Francisco, CA

7M
Shares

$48.8 Million
1.05% of portfolio
Black Rock Inc. New York, NY

6.59M
Shares

$45.9 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

6.43M
Shares

$44.8 Million
2.05% of portfolio

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $332M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Account